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Introduction
DCs possess specialized features, such as pathogen
recognition, antigen capturing and processing machinery,
migratory capacity and costimulatory molecules, that allow
them to act as the professional antigen presenting cells
(APC) [1]. DCs represent the interface between the uni-
verse of foreign and tissue-specific antigens and T lympho-
cytes. They  also play a role in all aspects of T-cell
responses, from the deletion of self-reactive thymocytes to
the generation of effector and memory cells, as well as the
induction of peripheral tolerance.
In this review, we shall discuss how DCs provide a qualita-
tive and quantitative framework for T-cell antigen recogni-
tion. We shall first summarize the requirements for T-cell
activation and differentiation in terms of concentration of
peptide–MHC complexes, costimulatory molecules and
cytokines. We shall then consider how DCs assemble
these components and deliver them, as discrete short-
lived packets, to the T-cell areas. Finally, we shall discuss
how the nature of the DC maturation stimuli determines
the density and quality of antigen-carrying DCs and, con-
sequently, the magnitude and class of T-cell responses.
Activation and differentiation of naïve T
lymphocytes
The signals that lead to T-cell activation are generated at
the level of the immunological synapse, a specialized area
of contact between T cells and APC where adhesion mol-
ecules and TCRs segregate into distinct supramolecular
complexes [2,3]. At the synapse, the TCRs are sequen-
tially triggered by peptide–MHC complexes, a process
that allows the signal to be sustained for as long as the
synapse is in place [4,5]. Synapses are stable in the
absence of disturbing influences, but they can be dis-
rupted by cell division, by death of APC or by external
influences, such as collagen or chemokines. T cells contin-
uously search for antigen and can rapidly shift from one
APC to another offering a higher level of stimulation. While
the duration of TCR stimulation depends on the duration
of the synapse, the intensity of signal that T cells receive is
dependent both on the level of peptide–MHC complexes
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that trigger TCRs and the level of costimulatory molecules
that amplify the signalling process [6].
The efficiency of signal transduction varies with the nature
of the APC and the T cell’s developmental stage [6,7]. In
activated, effector and memory T cells, TCR triggering is
efficiently coupled to signal transduction pathways so that
the cells can respond to low doses of antigens even in the
absence of costimulation. In contrast, TCRs are ineffi-
ciently coupled in naïve T cells. Engagement of CD28 by
B7 molecules expressed by professional APC recruits
membrane rafts containing kinases and adapters to the
synapse, and amplifies up to 100-fold the signalling
process initiated by the TCRs. In the absence of costimu-
lation, naïve T cells can thus be activated only by extremely
high (nonphysiologic) doses of antigens and they require a
prolonged stimulation, while in the presence of costimula-
tion they can respond to ~100-fold lower doses of antigen
and can also respond more rapidly. Depending on the
antigen dose and the level of costimulation, naïve T cells
require between 6 and >30 hours of TCR stimulation to
become committed to cell division, while memory/effector
T cells respond within 0.5–2 hours [7].
Once committed to division, T cells proliferate rapidly in
response to IL-2, which is produced in an autocrine or
paracrine fashion by activated T cells. We have shown
that the duration of TCR stimulation together with polariz-
ing cytokines determines the progressive differentiation of
CD4+ and CD8+ T cells, leading to the generation of ter-
minally differentiated effector cells as well as intermedi-
ates [8,9]. T cells that receive a short TCR stimulation
proliferate, but fail to differentiate to effector cells and
retain the lymph-node homing capacity characteristic of
naïve T cells. In contrast, T cells that receive a prolonged
TCR stimulation in the presence of IL-12 or IL-4 differenti-
ate to Th1 or Th2 cells. As part of their differentiation pro-
gramme, Th1 and Th2 cells lose the lymph-node homing
receptors and acquire receptors that control their migra-
tion to inflamed nonlymphoid tissues where they can
execute effector functions.
T cells interact with DCs in a highly dynamic environment
where they have to compete to achieve a level of TCR
stimulation sufficient to drive their activation and differenti-
ation processes. We suggest that the progressive
process of T-cell differentiation combined with the sto-
chastic stimulation of proliferating T cells by random T
cell–DC interactions leads to the generation of both inter-
mediates and terminally differentiated cells within the
same responding clone (Fig. 1) (F Sallusto, unpublished
data). We consider this intraclonal diversification as a fun-
damental property of the immune system since, on the one
hand, it prevents clonal exhaustion and, on the other, it
allows the generation of distinct T-cell subsets that play a
role in effector and memory responses [5]. The intraclonal
differentiation model is supported by the existence of dis-
tinct subsets of memory cells: ‘central memory’ cells that
represent intermediates, and ‘effector memory’ cells that
represent terminally differentiated cells [10].
The DC maturation process
DCs that migrate from tissues to lymph nodes have a life
expectancy of only a few days and can therefore be
viewed as disposable packets, each carrying a given
amount of peptide–MHC complexes, costimulatory mole-
cules and cytokines. These packets are assembled during
DC maturation, a process that is initiated by pathogens
and/or inflammatory stimuli. The production of homoge-
neous populations of human immature DCs from human
peripheral blood monocytes cultured with granulocyte/
macrophage-colony-stimulating factor and IL-4 [11] has
been instrumental in identifying the maturation stimuli and
in dissecting the DC maturation process (Fig. 2).
DC maturation is triggered and modulated by a variety of
receptors for microbial products, cytokines and T cells
[12,13]. Human monocyte derived and myeloid DCs express
several Toll-like receptors such as TLR2 and TLR4 that
trigger maturation in response to bacterial peptidoglycan
Figure 1
Stochastic stimulation of proliferating T cells leads to intraclonal
functional diversification. By establishing immunological synapses with
dendritic cells (DCs), naïve T cells (green) achieve stimulation and
become committed to proliferate in response to autocrine or paracrine
IL-2. T-cell receptor stimulation is sustained by serial encounters with
DCs and, in the presence of polarizing cytokines (IL-12 and IL-4, not
shown), drives T-cell differentiation to Th1 or Th2 effector cells that
have lost CCR7 expression (red). T cells receiving a shorter stimulation
do not acquire effector function and do retain lymph-node homing
capacity (yellow). An excessive stimulation leads to activation-induced
cell death (black).S129
and lipopolysaccharide, respectively. Interestingly, these
receptors are absent in plasmacytoid DCs (also known as
interferon-producing cells [IPC]) that instead express
TLR9, which mediates the response to CpG DNA [14,15].
The differential responsiveness of myeloid and plasmacy-
toid DCs to pathogens underlines a division of labour
between human DC subsets. DC maturation can be also
triggered by tumour necrosis factor (TNF)-α and IL-1, and
can be inhibited by IL-10. Finally, all DC types are exquis-
itely sensitive to T-cell feedback signals delivered by acti-
vated T cells through CD40 ligand (CD40L).
The maturation process coordinately regulates antigen
capturing, processing and presentation, expression of
costimulatory molecules, cytokine production and lifespan.
Immature DCs are extremely efficient in antigen capture
since they possess high levels of constitutive
macropinocytosis and express endocytic receptors for
microbial patterns, such as the mannose receptor [16].
Maturation increases synthesis of MHC class II molecules,
while decreasing their degradation, thus favouring the
rapid accumulation of long-lived peptide–MHC com-
plexes, which are retained for several days, while class II
synthesis is shut off [17]. Presentation on MHC class I
molecules is also enhanced by an approximately 10-fold
increase in the rate of synthesis, which is sustained in
mature DCs [18]. DCs are capable of transporting phago-
cytosed antigens from the endocytic compartment to the
cytosol, leading to their ‘cross-presentation’ to CD8+
T cells [19,20]. Finally, maturation stimuli upregulate the
expression of B7.1 and B7.2, thus enhancing the T-cell
stimulatory capacity of DCs. While the upregulation of
MHC molecules ensures higher capacity for antigen pre-
sentation, upregulation of costimulatory molecules ensures
an efficient amplification of signalling in naïve T cells.
Cytokine production by DCs is subject to a tight regulation,
which is particularly relevant in the case of IL-12 and IFN-I,
the major Th1-polarizing cytokines [21]. IL-12 production is
elicited by most pathogens and is boosted by activated T
cells through CD40L [22]. In contrast, IL-12 is not induced
by other maturation stimuli such as TNF-α, IL-1, and
cholera toxin. IL-12 production can be modulated by
cytokines and mediators present during induction of matu-
ration: IFN-γ and IL-4 enhance IL-12 production induced by
appropriate stimuli, while prostaglandin E2 and IL-10 exert
an inhibitory effect. In addition, one has to consider that IL-
12 production is restricted to a narrow temporal window,
8–16 hours after induction of DC maturation [9]. In
summary, the Th1-polarizing capacity of DCs is contingent
on a number of variables that include the lineage of DCs,
the microenvironment in which they are stimulated, the mat-
uration stimuli, and the kinetics of maturation (Fig. 3).
Dynamic changes in DC type and
concentration impact on T-cell responses
Because the half-life of mature DCs is short and because
cytokine production is transient, the number and type of
Available online http://arthritis-research.com/content/4/S3/S127
Figure 2
The maturation programme studied in monocyte-derived dendritic cells. DC, dendritic cells; ELC, endothelial-like cells; FcR, receptors for
crystallizable fragment [of antibody]; GM-CSF, granulocyte/macrophage-colony-stimulating factor; ICAM-1, intracellular adhesion molecule-1; LPS,
lipopolysaccharide; MIP, macrophage inflammatory protein; TARC, thymus- and activation-regulated chemokine.S130
DCs present in the T-cell areas will reflect, in highly
dynamic fashion, the conditions of the tissues from which
the lymph is drained. Under steady-state conditions, only a
few tissue-resident DCs ‘spontaneously’ mature and
migrate to the draining lymph nodes, carrying antigens and
apoptotic bodies taken up in peripheral tissues [23].
These migrating DCs do not induce effector responses,
but rather trigger an abortive T-cell proliferation that leads
to immunological tolerance [24,25]. It is possible that
spontaneously matured DCs deliver to T cells a qualita-
tively distinct tolerizing signal. Alternatively, according to
the progressive differentiation model, we suggest that the
low frequency and short lifespan of these DCs, together
with the low level of antigen and B7, may deliver a weak
stimulus to T cells, which is not sufficient to sustain prolif-
eration and to promote differentiation.
When pathogens (or adjuvants) are present in peripheral
tissues, resident DCs are activated en masse and migrate
to the draining lymph nodes. At the same time monocytes
are recruited from peripheral blood into inflamed tissues,
where they rapidly differentiate to DCs that capture anti-
gens and, on maturation, migrate to the draining lymph
nodes. This mechanism sustains antigen sampling and
presentation for extended periods of time. Maturing DCs
produce large amounts of inflammatory cytokines and
chemokines that promote monocyte recruitment [26]. The
relative role of tissue-resident DCs, such as Langerhans
cells and dermal DCs, versus recruited DCs, such as
monocyte-derived DCs and IPC, remains to be estab-
lished. Production of IFN-I by IPC may be important to
promote maturation of monocytes and to protect them
from the cytopathic effects of viruses [27,28].
In summary, under inflammatory conditions, the T-cell
areas of draining lymph nodes receive large numbers of
highly stimulatory DCs for a sustained period of time. The
high DC density and the high levels of antigen and B7
molecules deliver a strong and sustained stimulation to
specific T cells, leading to their rapid proliferation and dif-
ferentiation. High levels of IL-2 are produced under these
conditions and drive clonal expansion of committed T cells
irrespective of whether they continue to receive TCR stim-
ulation. One should also consider that DC–T cell interac-
tion results in a reciprocal stimulation. Activated T cells
trigger DCs via CD40L or TNF-related activation-induced
cytokine, improving their T-cell stimulatory capacity, boost-
ing IL-12 production, and prolonging their lifespan [29]. It
is possible that regulatory T cells may suppress antigen
presentation by DCs via production of inhibitory cytokines
or by direct contact [30].
There is growing evidence that the capacity of DCs to
induce Th1 or Th2 responses is contingent on appropriate
stimulation and timing (Fig. 3). As already discussed,
myeloid DCs produce IL-12 only in response to some
pathogens or CD40L, and within a narrow time window. In
addition, IPC produce large amounts of IFN-I, another
Th1-polarizing cytokine, in response to viruses but not in
response to CD40L; again, only within a narrow time
window. In contrast, Th2 responses may be induced by
DCs that do not produce Th1-polarizing cytokines, either
because they have been conditioned by nonpermissive
stimuli or because they have exhausted their IL-12 or IFN-
I-producing capacity. In this case, Th2 polarization is
driven by IL-4 produced by T cells themselves or derived
from exogenous sources, such as natural killer T cells or
mast cells. It is worth considering that the dynamics of DC
migration to the draining lymph nodes may lead to prefer-
ential generation of Th1 cells during the early phases of
the immune response, when active DCs enter the T-cell
areas in large numbers. This is followed by induction of
Th2 and nonpolarized T cells at later time points when the
influx of DCs ceases and the DCs surviving in the T-cell
area exhaust their IL-12-producing capacity [31].
Competition for DC shaping T-cell responses
The availability of antigen-presenting DCs and of antigen-
specific T-cell precursors represents the limiting factors in
the immune responses. There is growing evidence that
responding T cells compete in vivo for access to DCs and
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Figure 3
Reactivity, flexibility, kinetics and exhaustion in myeloid and
plasmacytoid dendritic cells (DCs). The figure summarizes the
properties of immature myeloid and plasmacytoid DCs. Indicated are
the most relevant Toll-like receptors (TLR) and chemokine receptors,
and the response to various maturation stimuli. DC1 and DC2 refer to
the capacity of the cells to induce Th1 and Th2 responses,
respectively. CD40L, CD40 ligand; LPS, lipopolysaccharide; PGE2,
prostaglandin E2.S131
that this competition can be relieved by providing more
DCs [32]. At the initial phase of a primary response, the low
frequency of naïve T cells specific for a given antigen makes
competition among responding cells unlikely. However, as
the responding cells proliferate, competition for sustained
TCR stimulation will increase, particularly among cells of the
same clone, which have the same avidity and occupy the
same niche. This intraclonal competition contributes to func-
tional diversification: T cells achieving a sustained stimula-
tion differentiate to effector cells, while those receiving a
short stimulation remain in an intermediate state giving rise
to central memory T cells. In contrast, interclonal competi-
tion may take place preferentially in secondary responses
due to the larger numbers of antigen-specific cells present,
and may therefore explain the selection of high-avidity
T cells under these circumstances.
Conclusions
It is becoming increasingly clear that DCs provide the
adaptive immune system with the essential function of
context discrimination. DCs can integrate multiple stimuli
from pathogens, inflammatory cytokines and T cells, and
can provide distinct outputs in terms of antigen presenta-
tion, costimulation and cytokine production. Like other
cells involved in the innate immune response, DCs
produce large amounts of inflammatory chemokines that
contribute to the recruitment of DC precursors in inflamed
tissues, thus sustaining antigen sampling in peripheral
tissue and presentation to T cells in lymph nodes. Finally,
the T-cell activation and differentiation programme trans-
lates antigen concentration, cytokine and costimulatory
molecule composition, and DC density into distinct cell
fates ranging from tolerance to inflammation, cytotoxicity
and memory.
Glossary of terms
APC = antigen presenting cells; CD40L = CD40 ligand;
DC = dendritic cell; IPC = interferon-producing cells.
Acknowledgement
A Lanzavecchia is supported by the Helmut Horten Foundation and by
the Swiss National Science Foundation (grant no. 31-63885). This
work was supported in part by the European Community (contract no.
QLK2-CT-201-0105).
References
1. Banchereau J, Steinman RM: Dendritic cells and the control of
immunity. Nature 1998, 392:245-252. [general reference]
2. Monks CR, Freiberg BA, Kupfer H, Sciaky N Kupfer A: Three-
dimensional segregation of supramolecular activation clus-
ters in T cells. Nature 1998, 395:82-86. [general reference]
3. Grakoui A, Bromley SK, Sumen C, Davis MM, Shaw AS, Allen PM,
Dustin ML: The immunological synapse: a molecular machine
controlling T cell activation. Science 1999,  285:221-227.
[general reference]
4. Lanzavecchia A, Iezzi G, Viola A: From TCR engagement to T
cell activation: a kinetic view of T cell behavior. Cell 1999, 96:
1-4. [general reference]
5. Lanzavecchia A, Sallusto F: Antigen decoding by T lympho-
cytes: from synapses to fate determination. Nat Immunol
2001, 2:487-492. [general reference]
6. Viola A, Schroeder S, Sakakibara Y, Lanzavecchia A: T lympho-
cyte costimulation mediated by reorganization of membrane
microdomains. Science 1999, 283:680-682. [general reference]
7. Iezzi G, Karjalainen K, Lanzavecchia A: The duration of antigenic
stimulation determines the fate of naive and effector T cells.
Immunity 1998, 8:89-95. [general reference]
8. Iezzi G, Scheidegger D, Lanzavecchia A: Migration and function
of antigen-primed nonpolarized T lymphocytes in vivo. J Exp
Med 2001, 193:987-993. [general reference]
9. Langenkamp A, Messi M, Lanzavecchia A, Sallusto F: Kinetics of
dendritic cell activation: impact on priming of TH1, TH2 and
nonpolarized T cells. Nat Immunol 2000, 1:311-316. [general
reference]
10. Sallusto F, Lenig D, Forster R, Lipp M, Lanzavecchia A: Two
subsets of memory T lymphocytes with distinct homing
potentials and effector functions. Nature 1999, 401:708-712.
[general reference]
11. Sallusto F, Lanzavecchia A: Efficient presentation of soluble
antigen by cultured human dendritic cells is maintained by
granulocyte/macrophage colony-stimulating factor plus inter-
leukin 4 and downregulated by tumor necrosis factor alpha. J
Exp Med 1994, 179:1109-1118. [general reference]
12. Reis e Sousa C, Sher A, Kaye P: The role of dendritic cells in
the induction and regulation of immunity to microbial infec-
tion. Curr Opin Immunol 1999, 11:392-399. [general reference]
13. Lanzavecchia A, Sallusto F: The instructive role of dendritic
cells on T cell responses: lineages, plasticity and kinetics.
Curr Opin Immunol 2001, 13:291-298. [general reference]
14. Kadowaki N, Ho S, Antonenko S, Malefyt RW, Kastelein RA, Bazan
F, Liu YJ: Subsets of human dendritic cell precursors express
different toll-like receptors and respond to different microbial
antigens. J Exp Med 2001, 194:863-869. [general reference]
15. Jarrossay D, Napolitani G, Colonna M, Sallusto F, Lanzavecchia A:
Specialization and complementarity in microbial molecule
recognition by human myeloid and plasmacytoid dendritic
cells. Eur J Immunol 2001, 31:3388-3393. [general reference]
16. Sallusto F, Cella M, Danieli C, Lanzavecchia A: Dendritic cells
use macropinocytosis and the mannose receptor to concen-
trate macromolecules in the major histocompatibility complex
class II compartment: downregulation by cytokines and bac-
terial products. J Exp Med 1995, 182:389-400. [general refer-
ence]
17. Cella M, Engering A, Pinet V, Pieters J, Lanzavecchia A: Inflam-
matory stimuli induce accumulation of MHC class II com-
plexes on dendritic cells. Nature 1997, 388:782-787. [general
reference]
18. Cella M, Salio M, Sakakibara Y, Langen H, Julkunen I, Lanzavec-
chia A: Maturation, activation, and protection of dendritic cells
induced by double-stranded RNA. J Exp Med 1999, 189:821-
829. [general reference]
19. Albert ML, Sauter B, Bhardway N: Dendritic cells acquire
antigen from apoptotic cells and induce class I-restricted
CTLs. Nature 1998, 392:86-89. [general reference]
20. Rodriguez A, Regnault A, Kleijmeer M, Ricciardi-Castagnoli P,
Amigorena S: Selective transport of internalized antigens to
the cytosol for MHC class I presentation in dendritic cells. Nat
Cell Biol 1999, 1:362-368. [general reference]
21. Kalinsky P, Hilkens C, Wierenga E, Kapsenberg M: T cell
priming by type-1 and type-2 polarized dendritic cells: the
concept of a third signal. Immunol Today 1999, 20:561-567.
[general reference]
22. Cella M, Scheidegger D, Palmer Lehmann K, Lane P, Lanzavec-
chia A, Alber G: Ligation of CD40 on dendritic cells triggers
production of high levels of interleukin-12 and enhances T
cell stimulatory capacity: T–T help via APC activation. J Exp
Med 1996, 184:747-752. [general reference]
23. Huang FP, Platt N, Wykes M, Major JR, Powell TJ, Jenkins CD,
MacPherson GG: A discrete subpopulation of dendritic cells
transports apoptotic intestinal epithelial cells to T cell areas
of mesenteric lymph nodes. J Exp Med 2000, 191:435-444.
[general reference]
24. Kurts C, Kosaka H, Carbone FR, Miller JF, Heath WR: Class I-
restricted cross-presentation of exogenous self-antigens
leads to deletion of autoreactive CD8(+) T cells. J Exp Med
1997, 186:239-245. [general reference]
25. Hernandez J, Aung S, Redmond WL, Sherman LA: Phenotypic and
functional analysis of CD8(+) T cells undergoing peripheral
Available online http://arthritis-research.com/content/4/S3/S127S132
deletion in response to cross-presentation of self-antigen. J
Exp Med 2001, 194:707-717. [general reference]
26. Sallutso F, Palermo B, Lenig D, Meittinen M, Matikainen S,
Julkunen I, Forster R, Burgstahler R, Lipp M, Lanzevecchia A: Dis-
tinct patterns and kinetics of chemokine production regulate
dendritic cell function. Eur J Immunol 1999,  29:1617-1625.
[general reference]
27. Siegal FP, Kadowaki N, Shodell M, Fitzgerald-Bocarsly PA, Shah
K, Ho S, Antonenko S, Liu YJ: The nature of the principal type 1
interferon-producing cells in human blood. Science 1999,
284:1835-1837. [general reference]
28. Cella M, Jarrossay D, Facchetti F, Alebardi O, Nakajima H, Lanza-
vecchia A, Colonna M: Plasmacytoid monocytes migrate to
inflamed lymph nodes and produce large amounts of type I
interferon. Nat Med 1999, 5:919-923. [general reference]
29. Wong BR, Josien R, Lee SY, Sauter B, Li H, Steinman RM, Choi
Y:  TRANCE (tumor necrosis factor [TNF]-related activation-
induced cytokine), a new TNF family member predominantly
expressed in T cells, is a dendritic cell-specific survival factor.
J Exp Med 1997, 186:2075-2080. [general reference]
30. Vendetti S, Chai JG, Dyson J, Simpson E, Lombardi G, Lechler R:
Anergic T cells inhibit the antigen-presenting function of
dendritic cells. J Immunol 2000,  165:1175-1181. [general
reference]
31. Lanzavecchia A, Sallusto F: Dynamics of T lymphocyte
responses: intermediates, effectors and memory cells.
Science 2000, 290:92-97. [general reference]
32. Kedl RM, Rees WA, Hildeman DA, Schaefer B, Mitchell T, Kappler
J, Marrack P: T cells compete for access to antigen-bearing
antigen-presenting cells. J Exp Med 2000,  192:1105-1113.
[general reference]
Arthritis Research    Vol 4 Suppl 3 Sallusto and Lanzavecchia